Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
December 20, 2023 3:05 PM 1 min read

FactSet Research Systems' Revised Guidance Reflects Delayed Growth, Yet Analyst Anticipates Share Gains and Margin Expansion

by Nabaparna Bhattacharya Benzinga Editor
Follow
FDS Logo
FDSFactSet Research Systems Inc
$247.38-0.55%
Overview

F1Q24 top-line trends were in line, though revised guidance implies slowing growth, most prominently in F2Q24, according to the analyst.

FY2024 guidance for 6% ASV growth implies slower growth than in F1Q24.

Management cited: -40bps pricing pressure/realization; -30bps higher erosion (trimming subscriptions); and -25bps from delayed decision-making from clients (mostly in banking).

Per the analyst, FDS should continue to gain share in the market data industry as has been the case historically. 

The company has some buffers against economic cyclicality, as virtually all of its business is subscription-based, and has been expanding into the relatively more stable wealth industry, Silber adds.

The analyst projects future margin expansion, given management's increased focus there.

The analyst lowered the FY24 revenue estimate to $2.203 billion from $2.214 billion.

Price Action: FDS shares are trading higher by 0.79% to $452.18 on the last check Wednesday.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Posted In:
Analyst ColorEquitiesNewsPrice TargetReiterationMarketsAnalyst RatingsTrading IdeasGeneralBriefsExpert Ideas

BMO Capital Markets analyst Jeffrey M. Silber reiterated the Market Perform rating on FactSet Research Systems Inc. (NYSE:FDS), raising the price target to $447 from $436.

FDS reported Q1 FY24 sales growth of 7.4% Y/Y to $542.2 million, marginally beating the consensus of $540.36 million. 

FY2024 guidance was revised lower by 1% (ASV and revenue) due to pricing, erosion, and delayed client decision-making; management had previously been contemplating a 2H24 recovery, though the expected recovery has been pushed back a bit, the analyst notes.

FDS Logo
FDSFactSet Research Systems Inc
$247.38-0.55%
Overview
Comments
Loading...